Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,405
Total Claims
$1.1M
Drug Cost
351
Beneficiaries
$3,201
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+200%
Cost per patient vs peers
$3,201 vs $1,068 avg
+104%
Brand preference vs peers
18.4% vs 9.0% avg
Brand vs Generic
Brand: 1,680 claims · $952K
Generic: 7,455 claims · $158K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 107 | $109K |
| Apixaban | 104 | $108K |
| Dulaglutide | 46 | $61K |
| Budesonide/Formoterol Fumarate | 100 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 89 | $48K |
| Sitagliptin Phosphate | 39 | $35K |
| Fluticasone/Umeclidin/Vilanter | 38 | $35K |
| Linaclotide | 41 | $34K |
| Empagliflozin | 26 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 54 | $26K |
| Tiotropium Bromide | 33 | $24K |
| Insulin Aspart | 32 | $24K |
| Estrogens, Conjugated | 32 | $22K |
| Tiotropium Bromide | 16 | $19K |
| Umeclidinium Bromide | 37 | $19K |
Prescribing Profile
Patient Profile
67
Avg Age
51%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data